20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences

21st World Hematology Congress

Madrid, Spain

29th International Oncology Summit

Chicago, USA

37th Global Summit on Pediatrics

Madrid, Spain

14th Annual Conference on Stem Cells and Regenerative Medicine

Kuala Lumpur, Malaysia
Journal Flyer
Flyer image

Apollina Goel

Apollina Goel

Apollina Goel
Department of Radiation Oncology
University of Iowa, USA


Dr. Goel is currently an Assistant Professor in the Free Radical and Radiation Biology Program within the Department of Radiation Oncology at the University of Iowa, USA. Dr. Goel received her undergraduate degree in Biotechnology from Pune University, India. She pursued her doctorate in Biotechnology at Institute of Microbial Technology, India. Dr. Goel then undertook post-doctoral studies at University of Nebraska Medical center and at Mayo Clinic, USA. During her postdoctoral research at UNMC, she developed a radioimmunotherapy approach to the treatment of solid tumors. Subsequently she spent two years at Mayo Clinic studying the interactions between genes and transcription factors. During her next two years at Mayo clinic, Dr. Goel combined her basic and translational experience in multiple myeloma and non-Hodgkins lymphoma models. Dr. Goel is currently pursuing targeted radiotherapy (using bone-seeking radiotherapy and oncolytic viruses encoding for human sodium iodide symporter gene) with molecular drugs to target these B-cell malignancies. Dr. Goel has published over 25 papers in reputed journals, and authored several review articles and book chapters. She is serving as grant reviewer for several agencies and scientific reviewer for several journals.

Research Interest

Dr. Goel Research Interst includes Chemo-radiotherapy for hematological malignancies Understanding and circumventing resistance to radiotherapy in multiple myeloma and B-cell lymphoma.